Söndag 20 April | 10:29:44 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-02-26 13:00 Bokslutskommuniké 2025
2025-08-21 13:00 Kvartalsrapport 2025-Q2
2025-06-27 N/A X-dag ordinarie utdelning 2CUREX 0.00 SEK
2025-06-26 N/A Årsstämma
2025-02-27 - Bokslutskommuniké 2024
2024-12-18 - Extra Bolagsstämma 2024
2024-08-22 - Kvartalsrapport 2024-Q2
2024-05-24 - X-dag ordinarie utdelning 2CUREX 0.00 SEK
2024-05-23 - Årsstämma
2024-02-22 - Bokslutskommuniké 2023
2023-11-23 - Kvartalsrapport 2023-Q3
2023-11-14 - Extra Bolagsstämma 2023
2023-08-24 - Kvartalsrapport 2023-Q2
2023-05-29 - Kvartalsrapport 2023-Q1
2023-05-26 - X-dag ordinarie utdelning 2CUREX 0.00 SEK
2023-05-25 - Årsstämma
2023-02-23 - Bokslutskommuniké 2022
2023-02-10 - Extra Bolagsstämma 2022
2022-11-24 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-05-25 - X-dag ordinarie utdelning 2CUREX 0.00 SEK
2022-05-24 - Årsstämma
2022-05-24 - Kvartalsrapport 2022-Q1
2022-02-24 - Bokslutskommuniké 2021
2021-11-25 - Kvartalsrapport 2021-Q3
2021-08-26 - Kvartalsrapport 2021-Q2
2021-05-28 - X-dag ordinarie utdelning 2CUREX 0.00 SEK
2021-05-27 - Årsstämma
2021-05-27 - Kvartalsrapport 2021-Q1
2021-02-25 - Bokslutskommuniké 2020
2020-11-26 - Kvartalsrapport 2020-Q3
2020-08-27 - Kvartalsrapport 2020-Q2
2020-07-02 - Extra Bolagsstämma 2020
2020-05-29 - X-dag ordinarie utdelning 2CUREX 0.00 SEK
2020-05-28 - Årsstämma
2020-05-28 - Kvartalsrapport 2020-Q1
2020-02-28 - Bokslutskommuniké 2019
2019-11-22 - Kvartalsrapport 2019-Q3
2019-08-23 - Kvartalsrapport 2019-Q2
2019-05-29 - X-dag ordinarie utdelning 2CUREX 0.00 SEK
2019-05-28 - Årsstämma
2019-05-17 - Kvartalsrapport 2019-Q1
2019-04-02 - Extra Bolagsstämma 2019
2019-03-01 - Bokslutskommuniké 2018
2018-11-23 - Kvartalsrapport 2018-Q3
2018-08-24 - Kvartalsrapport 2018-Q2
2018-05-29 - X-dag ordinarie utdelning 2CUREX 0.00 SEK
2018-05-28 - Årsstämma
2018-05-18 - Kvartalsrapport 2018-Q1
2018-02-15 - Bokslutskommuniké 2017

Beskrivning

LandDanmark
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
2cureX är verksamt inom cancerbehandling. Idag tillhandahåller bolaget olika verktyg som används av läkare vid behandlingar för att mäta effekt och resistens hos cancerläkemedel på patientens egna cancerceller. Målet är att förkorta behandlingsperioden samt hitta rätt individuell behandling. Störst verksamhet innehas på den europeiska marknaden. Huvudkontoret ligger i Köpenhamn.
2025-04-14 12:00:00

The shareholders of 2cureX AB (publ) are hereby informed of the upcoming Annual General Meeting (AGM), which will take place on Thursday, June 26, 2025, at 15:00 CEST at the offices of Forvis Mazars, located at Nordenskiöldsgatan 11A, 211 19 Malmö, Sweden.

Agenda Highlight: Proposed Dividend Distribution

At the AGM, the Board of Directors will propose initiating dividend payments from the proceeds previously received through the sale of 2cureX A/S. As approved at the EGM held on July 12, 2024, 2cureX A/S was sold to a consortium of international investors for SEK 5.6 million.

Following this transaction, the Board resolved that the full amount would be distributed proportionally to 2cureX AB shareholders. After consultations with the Company’s newly appointed auditor, the Board has concluded that the dividend will need to be distributed in a number of tranches for accounting and compliance purposes.

A formal and detailed Notice of the AGM, including the exact amount of the first dividend tranche, will be published in advance of the meeting, in accordance with legal requirements.

Ole Thastrup, Chairman of the Board of Directors, commented:

“It is a pleasure to confirm that 2cureX AB will now begin distributing the proceeds from the sale of 2cureX A/S as dividend to our shareholders. While we had anticipated initiating payments earlier, the delay was due to an intense operational period within the company. Dividend payments from growth-stage companies are rare, and this move reflects our deep appreciation for the continued trust and support of our shareholders.”

For further details and updates regarding the AGM, please refer to the official notice to be published in due course.